OMCL
Omnicell, Inc. · Healthcare · Medical - Healthcare Information Services
Señales de momentum (gestores comparables):
amplitud de titulares +7.7% ·
flujo de acciones +1.0% ·
nuevas posiciones netas +7.1%
· fórmula
Acumulación amplia: acciones en aumento entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 98 | +2 | 36.92M | $1.52B | +8 | −7 |
| Q1 2026 | 100 | +1 | 36.98M | $1.23B | +6 | −5 |
| Q4 2025 | 99 | +2 | 40.13M | $1.82B | +2 | n/a |
| Q3 2025 | 18 | 0 | 22.98M | $699.67M | +1 | −1 |
| Q2 2025 | 15 | -1 | 21.34M | $627.32M | +1 | −2 |
| Q1 2025 | 13 | -1 | 6.74M | $235.79M | n/a | −1 |
| Q4 2024 | 14 | +1 | 6.20M | $275.97M | +1 | n/a |
| Q3 2024 | 12 | -1 | 3.89M | $169.70M | n/a | −1 |
| Q2 2024 | 13 | n/a | 3.69M | $99.83M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 2.24M | n/a | $99.93M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 1.10M | 0.0% | $49.18M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 3 | D. E. Shaw & Co. ✦ | 940.62K | 0.0% | $41.88M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 4 | Millennium Management ✦ | 499.80K | +29.4% | $22.25M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 456.34K | +79.3% | $20.32M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 325.56K | -23.0% | $14.49M | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 7 | Citadel Advisors ✦ | 250.35K | -16.7% | $11.15M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 8 | Two Sigma Investments ✦ | 141.74K | +44.2% | $6.31M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Arrowstreet Capital ✦ | 120.67K | Nuevo | $5.37M | 0.0% | New | 1 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 44.21K | +8.1% | $1.97M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Gotham Asset Management ✦ | 34.67K | -13.7% | $1.54M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Marshall Wace ✦ | 18.03K | -93.2% | $802,652 | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 13 | AQR Capital Management ✦ | 12.62K | -42.2% | $562,065 | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 14 | Bridgewater Associates ✦ | 4.96K | -72.3% | $220,775 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Arrowstreet Capital | $5.37M | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 2 tenedores, 5.77M acciones, $5.60M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.